Clinical Evaluation of Genetron IDH1 PCR Kit in Glioma Patients

Genetron Health1,192 enrolled

Overview

The purpose of this trail is to evaluate the performance of Genetron IDH1 PCR Kit in Glioma patients using real-time PCR method.

This trial follows the principle of synchronous blinding. The enrolled cases are coded, and the enrolled samples are detected with Genetron IDH1 PCR Kit and Sanger sequencing method. The results were determined independently according to the cutoff values or interpretation requirements provided by each method. Combined with the results of clinicopathological classification, the incidence of IDH1 gene R132H mutation in different subtypes was counted to evaluate the clinical performance of the Genetron IDH1 PCR Kit.

Study Type

OBSERVATIONAL

Enrollment

1,192

Conditions

Glioma, Malignant Glioma, Mixed

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: 1. Enroll cases in strict accordance with the requirements of the study 2. The remaining samples after routine clinical testing 3. The collection and processing of samples meet the requirements of standard laboratory operations and product instructions 4. The relevant information of the sample is complete, including sample number, gender, age, and possible clinical diagnosis information 5. Each sample must have HE staining results (hematoxylin-eosin staining) 6. Pathological examination diagnosed as glioma, other brain tumors or normal tissues 7. Number of samples: 10 pieces of each sample with a thickness of 10μm, and the tumor content is not less than 50% Exclusion Criteria: 1. Incomplete sample information 2. Severely contaminated samples 3. Samples that do not meet the requirements of sample collection and processing

Locations (4)

The First Hospital of Jilin University

Jilin, China

Huashan Hospital of Fudan University

Shanghai, China

West China Hospital of Sichuan University

Sichuan, China

The Second Affiliated Hospital of Zhejiang University

Zhejiang, China

Outcomes

Primary Outcomes

Efficacy of the Genetron IDH1 PCR Kit

The main purpose of this study is: by evaluating the Genetron IDH1 PCR Kit to compare the results of the Sanger sequencing method, and to calculate the coincidence rate and consistency of the two methods.

Time frame: 3 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.